Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status
Arash KarimiDepartment of Clinical Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, IranFatemeh NaeiniDepartment of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Science, Tehran, IranHamid Reza NiazkarBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, IranHelda TutunchiDepartment of Clinical Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, IranVali MusazadehDepartment of Community Nutrition, School of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, IranAta MahmoodpoorDepartment of Anesthesiology and Intensive Care, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, IranVahid AsghariazarDepartment of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, IranMajid MobasseriEndocrine Research Center, Tabriz University of Medical Sciences, Tabriz, IranAli Tarighat‐EsfanjaniDepartment of Clinical Nutrition, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran
2022en
ABI
Abstract
< 0.05). Supplementation with NC may be a promising treatment strategy for critically ill patients with sepsis. However, further experiments are suggested to investigate the effects of nano-curcumin on biochemical pathways involved in sepsis.
Identifiers
Citations and references
Cited by 20 references